Table of Contents
Chromatography Research International
Volume 2013, Article ID 315145, 12 pages
http://dx.doi.org/10.1155/2013/315145
Research Article

Development and Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Guaifenesin and Dextromethorphan Impurities in Pharmaceutical Formulations

1Analytical Research and Development, Integrated Product Development, Dr. Reddy’s Laboratories Limited, Bachupally, Hyderabad-500072, India
2School of Chemistry, Andhra University, Visakhapatnam, Andhra Pradesh 530003, India

Received 8 June 2013; Revised 9 August 2013; Accepted 9 August 2013

Academic Editor: Osama Y. Aldirbashi

Copyright © 2013 Thummala V. Raghava Raju et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. http://www.rxlist.com/organidin-nr-drug.htm.
  2. W. Zhang, T. Wang, L. Qin et al., “Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase,” The FASEB Journal, vol. 18, no. 3, pp. 589–591, 2004. View at Google Scholar · View at Scopus
  3. Dextromethorphan, NHTSA.
  4. “Child deaths lead to FDA hearing on cough, cold meds,” 2007, http://www.cnn.com/.
  5. B. KuKanich and M. G. Papich, “Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs,” Journal of Veterinary Pharmacology and Therapeutics, vol. 27, no. 5, pp. 337–341, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. “Kids' cough medicine no better than placebo,” San Francisco Chronicle, 2004.
  7. I. M. Paul, K. E. Yoder, K. R. Crowell et al., “Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents,” Pediatrics, vol. 114, no. 1, pp. e85–e90, 2004. View at Google Scholar · View at Scopus
  8. S. Görög, M. Babják, G. Balogh et al., “Drug impurity profiling strategies,” Talanta, vol. 44, no. 9, pp. 1517–1526, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. B. B. Sanjay, R. K. Bharati, S. J. Yogini, and A. S. Atul, “Impurity profile: significance in active pharmaceutical ingredient,” Eurasian Journal of Analytical Chemistry, vol. 2, pp. 32–53, 2007. View at Google Scholar
  10. ICH, “Impurities in new drug substances Q3A (R2),” 2006.
  11. ICH, “Impurities in new drug products Q3B (R2),” 2006.
  12. G. Grosa, E. D. Grosso, R. Russo, and G. Allegrone, “Simultaneous, stability indicating, HPLC-DAD determination of guaifenesin and methyl and propyl-parabens in cough syrup,” Journal of Pharmaceutical and Biomedical Analysis, vol. 41, no. 3, pp. 798–803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Senthilraja and P. Giriraj, “Reverse phase hplc method for the simultaneous estimation of terbutanile sulphate, bromhexine HCl and guaifenesin in cough syrup,” Asian Journal of Pharmaceutical and Clinical Research, vol. 4, no. 2, pp. 13–15, 2011. View at Google Scholar · View at Scopus
  14. M. L. Wilcox and J. T. Stewart, “HPLC determination of guaifenesin with selected medications on underivatized silica with an aqueous-organic mobile phase,” Journal of Pharmaceutical and Biomedical Analysis, vol. 23, no. 5, pp. 909–916, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Özdemir, H. Aksoy, E. Dinç, D. Bǎleanu, and S. Dermiş, “Determination of guaifenesin and dextromethorphan in a cough syrup by HPLC with fluorometric detection,” Revue Roumaine de Chimie, vol. 51, no. 2, pp. 117–122, 2006. View at Google Scholar · View at Scopus
  16. I. Demian, “High-performance liquid chromatography (HPLC) chiral separations of guaifenesin, methocarbamol, and racemorphan,” Chirality, vol. 5, no. 4, pp. 238–240, 1993. View at Google Scholar · View at Scopus
  17. S. Süzen, C. Akay, and Ş. Cevheroglu, “Simultaneous determination of guaiphenesin and codeine phosphate in tablets by high-performance liquid chromatography,” Farmaco, vol. 54, no. 10, pp. 705–709, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. S. M. Amer, S. S. Abbas, M. A. Shehata, and N. M. Ali, “Simultaneous determination of phenylephrine hydrochloride, guaifenesin, and chlorpheniramine maleate in cough syrup by gradient liquid chromatography,” Journal of AOAC International, vol. 91, no. 2, pp. 276–284, 2008. View at Google Scholar · View at Scopus
  19. V. Galli and C. Barbas, “High-performance liquid chromatographic analysis of dextromethorphan, guaifenesin and benzoate in a cough syrup for stability testing,” Journal of Chromatography A, vol. 1048, no. 2, pp. 207–211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Chen, J. Huang, Z. Kong, and D. Zhong, “Sensitive liquid chromatography-tandem mass spectrometry method for the simultaneous determination of paracetamol and guaifenesin in human plasma,” Journal of Chromatography B, vol. 817, no. 2, pp. 263–269, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. R. M. Gudipati, J. E. Wallace, and S. A. Stavchansky, “High performance liquid chromatography determination of guaifenesin in dog plasma,” Analytical Letters, vol. 24, pp. 265–274, 1991. View at Google Scholar
  22. Q.-H. Ge, Z. Zhou, X.-J. Zhi, L.-L. Ma, and C.-G. Ding, “Simultaneous determination of guaifenesin, bromhexine and ambroxol in human plasma by LC-MS/MS and its pharmacokinetic studies,” Chinese Pharmaceutical Journal, vol. 44, no. 13, pp. 1025–1028, 2009. View at Google Scholar · View at Scopus
  23. R. Rajagopalan, “Review of regulatory guidance on impurities,” Separation Science and Technology, vol. 5, pp. 27–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. ICH, Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), 2005.
  25. ICH, “Stability testing of new drug substances and products Q1A (R2),” 2003.
  26. ICH, “Photostability testing of new drug substances and products Q1B,” 1996.
  27. The United States Pharmacopeia, USP35-NF30: 3829–3837.
  28. European Pharmacopeia, 7.0: 1821-1822 & 2128-2129.
  29. P. Sunil Reddy, K. Sudhakar Babu, N. Kumar, and Y. V. V. Sasi Sekhar, “Development and validation of stability indicating the RP-HPLC method for the estimation of related compounds of guaifenesin in pharmaceutical dosage forms,” Pharmaceutical Methods, vol. 2, pp. 229–234, 2011. View at Google Scholar